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Abstract: Toxocara canis is a nematode of the family Ascaridae. Following ingestion by dogs, the infective eggs hatch and larvae
penetrate the gut wall and migrate into various tissues. There are two main clinical forms of T. canis infection; visceral larva migrans
and ocular larva migrans. Toxocariasis is treated with antiparasitic drugs, such as diethylcarbamazine, albendazole and mebendazole.
In this study, the effects of albendazole treatment on haematological and biochemical changes in healthy and T. canis infected mice
were evaluated. Four study groups were used: Group 1 was assigned as the control, Group 2 was given infective T. canis eggs (as
1500 infective eggs), Group 3 was given albendazole (as 100 mg/kg b.w.) and Group 4 was given T. canis and albendazole. Total
leukocyte counts, total eosinophil counts, differential leukocyte counts in the blood; and urea, creatine, aspartate aminotransferase
(AST), alanine aminotransferase (ALT) and alkaline phosphatase (ALP) activities in serum were determined on days 8, 15 and 28.
The data obtained from this study show that total leukocyte counts and total eosinophil counts increased significantly in T. canis
infected mice. These increases were observed in Group 2 in particular. Albendazole treatment in T. canis infected mice prevented
these increases to some degree. In addition, enzyme activities in serum changed with T. canis infection, but these changes were not
statistically significant.
Key Words: Toxocara canis, haematology, some biochemical parameters, albendazole, mouse

Sa¤l›kl› ve Toxocara canis ile Enfekte Farelerde Albendazolun Hematolojik ve Biyokimyasal
Parametrelere Etkileri
Özet: Toxocara canis Askaridae familyas›na ba¤l› bir nematottur. Enfektif yumurtalar›n a¤›z yoluyla köpekler taraf›ndan al›nmas›n›
takiben yumurtalar aç›l›r, larvalar ba¤›rsak duvar›na penetre olur ve daha sonra çeflitli dokulara göç eder. T. canis enfeksiyonunun
iki önemli klinik formu vard›r; bunlar visseral larva migrans› ve oküler larva migrans›d›r. T. canis enfeksiyonlar›n›n sa¤alt›m›nda
antiparaziter ilaç olarak dietilkarbamazin, albendazol ve mebendazol kullan›l›r. Bu çal›flma kapsam›nda sa¤l›kl› ve T. canis ile enfekte
edilen farelerde albendazol sa¤alt›m›n›n hematolojik ve biyokimyasal parametreler üzerine etkileri de¤erlendirilmifltir. Bu amaçla
çal›flmada 4 grup oluflturulmufltur; Grup 1 kontrol olarak tutulmufl, Grup 2’ye enfekte T. canis yumurtas› verilmifl (1500 enfekte
yumurta olacak flekilde), Grup 3’e albendazol uygulanm›fl (100 mg/kg canl› a¤›rl›k dozunda), Grup 4’e ise T. canis ve albendazol
birlikte verilmifltir. Fizyolojik ve biyokimyasal parametrelerin göstergesi olarak 8., 15. ve 28. günlerde kanda toplam lökosit say›s›,
toplam eozinofil say›s›, diferensiyel lökosit say›s› ve serumda üre, kreatinin, aspartat amino transferaz (AST), alanin aminotransferaz
(ALT), alkalen fosfataz (ALP) etkinlikleri saptanm›flt›r. Elde edilen sonuçlar T. canis ile enfekte farelerde toplam lökosit ve eozinofil
say›lar›n›n önemli oranda artt›¤›n› göstermifltir. Bu art›fllar özellikle 2. grupta gözlenmifltir. Bununla birlikte albendazol uygulanmas›
bu art›fllar› farkl› oranlarda olacak flekilde önlemifltir. T. canis enfeksiyonunda serum enzim aktivitelerinde de de¤ifliklikler meydana
gelmifltir; ancak bu de¤ifliklikler istatistiksel olarak önemli bulunmam›flt›r.
Anahtar Sözcükler: Toxocara canis, hematoloji, baz› biyokimyasal parametreler, albendazol, fare
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Introduction

Materials and Methods

Toxocara canis is a nematode of the family Ascaridae,
whose adult form inhabits the proximal small intestine of
its mammalian definitive hosts, namely canids and felids.
T. canis completes its life cycle in dogs, with humans
acquiring the infection as accidental hosts. Following
ingestion by dogs, the infective eggs hatch and larvae
penetrate the gut wall and migrate into various tissues,
where they encyst if the dog is older than 5 weeks. Many
human infections are asymptomatic, with only
eosinophilia and positive serology. The two main clinical
presentations of toxocariasis are visceral larva migrans
(VLM) and ocular larva migrans (OLM). In VLM, which
occurs mostly in pre-school children, the larvae invade
multiple tissues such as the liver, heart, lungs, brain,
muscle, and cause various symptoms including fever,
anorexia, weight loss, coughing, wheezing, rashes,
hepatosplenomegaly and hypereosinophilia. Deaths rarely
occur due to cardiac, pulmonary or neurological
involvement. In OLM, the larvae produce various
ophthalmologic lesions, which in some cases have been
misdiagnosed as retinoblastoma, resulting in surgical
enucleation. OLM often occurs in older children or young
adults, with only rare eosinophilia or visceral
manifestations. In this parasitic disease the diagnosis does
not rest on identification of the parasite. Since the larvae
do not develop into adults in humans, a stool examination
would not detect any Toxocara eggs. However, the
presence of Ascaris and Trichuris eggs in faeces,
indicating faecal exposure, increases the probability of
Toxocara in the tissues. For both VLM and OLM a
presumptive diagnosis rests on clinical signs, history of
exposure to puppies, laboratory findings (including
eosinophilia) and the detection of antibodies to Toxocara
(1-5).

Adult T. canis were collected from the puppies’ faeces.
Eggs were obtained from the uteri of adult female worms
and stirred in a magnetic stirrer for 10 min with 1%
sodium hypochloride. This suspension was filtered
through a sieve with 150 µm pores. The filtrate was
centrifuged three times at 5000 g for 3 min with 0.9%
NaCl solution in order to remove the sodium
hypochloride. The eggs were incubated in 0.5% formalin
at 26 ºC for 4 weeks to allow embryonic development.
Before the application of the embryonated egg the
suspension was centrifuged at 5000 g for 3 min and
washed three times in sterile distilled water to remove
formalin. At the end of this process distilled water was
added to the remaining sediment to reach a concentration
of approximately 1500 embryonated eggs in 0.5 ml (11).
Each mouse in Group 2 and Group 4 was inoculated with
0.5 ml of this egg suspension.

Treatment of VLM and OLM is mostly supportive. The
Medical Letter recommends diethylcarbamazine,
albendazole and mebendazole as the drugs of choice. For
severe symptoms or eye involvement, corticosteroids can
be used in addition (6-10).
In this study we aimed to evaluate the haematological
and biochemical changes in T. canis infected mice.
Therefore, the effect of albendazole on this situation was
observed. Total leukocyte counts, total eosinophil counts
and differential leukocyte counts in blood and urea,
creatine, aspartate aminotransferase (AST) alanine
aminotransferase (ALT) and alkaline phosphatase (ALP)
activities in serum were determined on days 8, 15 and 28.
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Swiss Albino mice weighing 30-35 g were used in this
study. The mice were assigned into four groups,
consisting of 21 mice each, totalling 84 mice. The mice of
Group 1 were used as a control; these were fed a
commercial ration, and not given T. canis, or albendazole.
The mice in Group 2 were given infective T. canis eggs
(1500 infective eggs in 0.5 ml) but no albendazole
application. Embryonated eggs were placed in the
stomach with a blunt needle. The mice in Group 3 were
given albendazole (Andazol susp 2%, Biofarma Drug
Corp., Istanbul, Turkey) for five consecutive days at 100
mg/kg body weight. The mice in Group 4 were previously
infected with T. canis eggs (1500 infective eggs in 0.5
ml) and then albendazole was given for five consecutive
days at 100 mg/kg body weight.
Blood samples were collected from seven mice by
cardiac puncture on days 8, 15 and 28. Haematological
changes were evaluated by determining the total
leukocyte and eosinophil counts. Furthermore differential
leukocytes counts were made on the smears stained with
May Grunwald Giemsa for this evaluation in these periods
(12). Biochemical changes were determined by analysing
urea (mg/dl), creatine (mg/dl), AST, ALT and ALP
(evaluated as U/L ) activities in serum during these study
periods. These analyses were performed automatically
with a Shimadzu CL 770 spectrophotometer.
The data were analyzed by one-way analysis of
variances (ANOVA) when significant treatment effects
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were detected; Duncan’s multiple range test was used to
identify specific differences between treatments, with
means at a probability level of 5%.

Results
Total leukocyte counts, total eosinophil counts,
differential leukocytes counts and urea, creatine, AST,
ALT and ALP activities were determined in blood collected
from mice on post-infection days 8, 15 and 28. The total
leukocytes and eosinophil counts increased dramatically in
Group 2, which had only infective T. canis eggs. These
findings regarding the total leukocyte and eosinophil
counts are shown in Tables 1 and 2. The eosinophil
counts increased on days 8 and 15 in Group 2 in
particular compared to the control and other treatment
groups. In these periods the total eosinophil counts were

3033.40 ± 2187.36 and 1322.0 ± 742.66
(eosinophil/µl), respectively. On the other hand, the total
leukocyte counts were also high on days 8, 15 and 28;
122.20 ± 37.07, 139.20 ± 38.17, and 166.25 ± 67.04
(x102/µl), respectively. Therefore, changes in lymphocyte,
neutrophil, eosinophil, monocyte and basophile counts
were observed in T. canis infected mice and other
treatment groups (Table 3). In addition, urea, creatine,
AST, ALT and ALP activities were measured in the serum
of these study groups (Table 4). According to the results,
serum urea, creatine and ALP activities decreased in T.
canis infected mice in Group 2. AST and ALT activities in
serum therefore increased in this group compared to the
control and other treatment groups. The levels of AST
activities were (as IU/L), 248.80 ± 36.75 on day 8,
347.50 ± 56.55 on day 15 and 393.25 ± 118.34 on day
28.

Table 1. Total leukocyte counts in all study groups on days 8, 15 and 28 (x102/µl).
Groups
Group 1
(n=21)
Group 2
(n=21)
Group 3
(n=21)
Group 4
(n=21)
a,b,c

Day 8
66.75±10.46

Day 15
a

a

81.40±41.07

(55.0-77.0)

62.40±12.54

(46.0-147.0)
b

122.20±37.07

(102.0-198.0)
a

93.25±15.94

(23.5-82.5)
114.30 ±47.07

103.00±26.47

(58.5-187.5)

b

166.25±67.04
(121.0-266.0)

ab

58.40±25.34

(80.0-116.0)
b

a

(49.0-82.0)
b

139.20±38.17

(73.0-157.5)
54.70±25.10

Day 28

a

(33.0-98.0)
ab

(78.0-134.0)

c

114.50±10.40
(105.0-124.0)

: Means within the same columns with different letters are statistically significant (p < 0.05).

Table 2. Total eosinophil counts in all study groups on days 8, 15 and 28 (eosinophil/µl).
Groups

Day 8

Group 1

433.0±180.12 a

(n=21)
Group 2

Day 15
266.40±152.88

(270.0-687.0)
b

1322.0±742.66

(370.0-5810.0)

(705.0-2610.0)

Group 3

691.0±391.84 a

201.25±130.02

(n=21)

(350.0-12000.0)

Group 4

1070.0±462.23

a,b

(540.0-1600.0)

a

325.0±234.89

b

790.0±655.14

a

152.20±48.67

a

636.60±352.79

(100.0-485.0)

3033.40±2187.36

(n=21)

(n=21)

Day 28

a

(100.0-670.0)

(608.0-1165.0)

b

(320.0-1935.0)

(80.0-335.0)
852.60±199.37

ab

a

(85.0-215.0)
ab

(250.0-1093.0)

: Means within the same columns with different letters are statistically significant (p < 0.05).
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Table 3. Differential leukocyte counts in all study groups on days 8, 15 and 28 (%).

Days

Lymphocytes

Day 8

Neutrophils
Eosinophils
Monocytes
Basophiles

Lymphocytes

Day 15

Neutrophils
Eosinophils
Monocytes
Basophiles
Lymphocytes

Day 15

Neutrophils
Eosinophils
Monocytes

Group 1
(n=21)

Group 2
(n=21)

Group 3
(n=21)

Group 4
(n=21)

59.40±16.04 a
(33.0-76.0)
25.40±15.89
(57.0-74.0)
6.4±2.96 a
(3.0-10.0)
8.80±1.92 b
(6.0-11.0)
-

38.60±5.63 b
(32.0-46.0)
26.40±8.17
(35.0-67.0)
28.8±13.23 c
(10.0-45.0)
7.2±1.92 ab
(5.0-10.0)
0.60±0.54
(0.0-1.0)

54.25±14.00 ab
(34.0-66.0)
27.50±11.84
(51.0-75.0)
9.75±7.13 ab
(1.0-18.0)
6.5±3.0 ab
(4.0-10.0)
0.2±0.44
(0.0-1.0)

45.60±15.96 ab
(26.0-61.0)
28.00±8.45
(36.0-73.0)
21.60±11.26 bc
(6.0-36.0)
4.6±3.2 a
(1.0-9.0)
0.20±0.44
(0.0-1.0)

66.60±14.48 a
(50.0-88.0)
25.60±13.48
(11.0-43.0)
4.20±2.04 a
(2.0-6.0)
5.60±2.30 a
(2.0-8.0)
-

50.8±8.13 ab
(39.0-59.0)
33.00±12.62
(20.0-53.0)
17.75±4.19 b
(12.0-22.0)
5.60±2.88 a
(2.0-8.0)
-

52.50±18.71 ab
(34.0-74.0)
25.75±11.08
(13.0-40.0)
4.0±3.0 a
(1.0-7.0)
14.25±8.26 b
(8.0-26.0)
-

46.20±12.02 b
(33.0-62.0)
27.60±8.04
(19.0-36.0)
14.40±7.36 b
(8.0-27.0)
7.20±3.27 b
(3.0-12.0)
-

64.60±6.10
(57.0-74.0)
16.80±8.70
(5.0-24.0)
8.4±4.2 ab
(3.0-14.0)
10.20±4.7
(6.0-18.0)
-

56.00±12.32
(35.0-67.0)
23.40±8.20
(19.0-38.0)
13.75±0.95 b
(13.0-15.0)
12.20±3.4
(9.0-18.0)
-

58.00±9.84
(51.0-75.0)
22.80±6.53
(13.0-30.0)
5.40±1.14 a
(4.0-7.0)
7.2±1.30
(5.0-8.0)
-

56.20±13.47
(36.0-73.0)
22.20±11.43
(9.0-40.0)
12.80±6.01 b
(5.0-19.0)
8.60±4.61
(5.0-16.0)
-

a,b,c. Means within the same row with different letters are statistically significant (p < 0.05).

Discussion
Worldwide, several hundred million domestic dogs are
infected with the parasitic nematode T. canis. The adult
worms reside in the gastrointestinal tract and produce
eggs which are subsequently covered with faeces and
extruded into the environment. One T. canis adult female
can produce 20,000 eggs per day, and since intestinal
parasite burdens range from one to several hundred
worms, infective animals contaminate the environment
with millions of eggs every day (1,2,5). Toxocariasis is
treated
with
antiparasitic
drugs,
such
as
diethylcarbamazine, albendazole and mebendazole, and
these are usually combined with anti-inflammatory
medications (6-10).
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In this study, we aimed to evaluate the haematological
and biochemical changes in T. canis infected mice.
Therefore, the effects of drug treatment on T. canis
infection were also evaluated. In many helminth-infected
hosts, the number of eosinophils in particular increases
dramatically, often without any concurrent increases in
the number of other leukocytes, so that eosinophil
becomes the dominant cell type (13-19). Many
experimental investigations have revealed this. Takamoto
et al. (18) studied eosinophilia, IgE production and
cytokine production by lung T cells in surface
CD4–deficient mutant mice infected with T. canis. The
results show that eosinophil counts reached a peak on day
10 in T. canis infected mice. In another study, Takamoto
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Table 4. Enzymes activities in serum all study groups on days 8, 15 and 28.

Day 8

Days

Days

Group 1
(n=21)

Group 2
(n=21)

Group 3
(n=21)

Group 4
(n=21)

66.20±14.61 a
(51.0-85.0)
0.56±8.94 a
(0.50-0.70)
188.25±100.53
(78.0-275.0)

62.00±11.33 a
(48.0-79.0)
0.48±4.47 ba
(0.4-0.5)
248.80±36.75
(211.0-303.0)

99.25±25.69 b
(65.0-119.0)
0.47±5.00 ba
(0.4-0.5)
267.33±27.53
(239.0-294.0)

57.00±16.23 a
(43.0-80.0)
0.447±5.47 b
(0.4-0.5)
217.40±47.65
(160.0-284.0)

29.00±4.54
(25.0-35.0)
86.20±30.62
(55.0-136.0)

43.00±17.95
(31.0-74.0)
83.20±27.50
(52.0-120.0)

40.75±4.5
(37.0-47.0)
121.50±27.48
(96.0-160.0)

31.40±7.5
(23.0-41.0)
92.60±43.02
(65.0-169.0)

Urea
(mg/dl)
Creatine
(mg/dl)
AST
(U/L)

60.20±10.55
(48.0-74.0)
0.52±4.4 ab
(0.50-0.60)
293.25±139 .62
(150.0-476.0)

55.40±6.76
(44.0-62.0)
0.46±5.4 a
(0.40-0.50)
347.50±56.55
(284.0-419.0)

63.66±16.25
(51.0-82.0)
0.70±0.10 bc
(0.60-0.80)
334.33±29.77
(300.0-353.0)

67.00 ±8.62
(51.0-75.0)
0.83±0.24 c
(0.40-1.10)
294.00±120.03
(169.0-484.0)

ALT
(U/L)
ALP
(U/L)

54.00±44.93
(25.0-132.0)
147.00±51.0 ab
(70.0-203.0)

43.20±10.80
(35.0-62.0)
87.00±33.66 a
(60.0-140.0)

47.00±18.00
(29.0-65.0)
196.66±86.3 b
(115.0-287.0)

45.83±12.51
(31.0-58.0)
106.83±28.50 a
(78.0-153.0)

Urea
(mg/dl)
Creatine
(mg/dl)
AST
(U/L)

52.40±5.72 a
(44.0-57.0)
0.60±0.23
(0.40-1.0)
331.80±179.60
(200.0-648.0)

61.50±4.04 a
(56.0-65.0)
0.40±1.8
(0.40-0.40)
393.25±118.34
(296.0-559.0)

80.00±10.43 b
(66.0-97.0)
0.46±5.16
(0.4-0.5)
255.66±99.07
(166.0-432.0)

79.66±16.77 b
(65.0-107.0)
0.58±0.21
(0.4-1.0)
234.00±115.55
(89.0-377.0)

ALT
(U/L)
ALP
(U/L)

53.00±19.81
(38.0-81.0)
136.6±31.02 ab
(100.0-170.0)

45.5±14.47
(29.0-60.0)
147.0±51.98 ab
(88.0-200.0)

49.00±3.464
(44.0-53.0)
203.5±75.28 b
(89.0-286.0)

41.16±12.46
(24.0-52.0)
109.66±33.05 a
(55.0-140.0)

Urea
(mg/dl)
Creatine
(mg/dl)
AST
(U/L)

Day 15

Day 15

ALT
(U/L)
ALP
(U/L)

a,b,c. Means within the same row with different letters are statistically significant (p < 0.05).

et al. (17) investigated, eosinophilia, parasite burden and
lung damage in T. canis infection in C57B1/6 mice
genetically deficient in IL-5 was examined. At the end of
the study, it was revealed that eosinophil counts increased
markedly in their peripheral blood. Another study, by
Sugane et al. (16), looked at eosinophilia, IL-5 levels and
the recovery of larvae in IL-5 transgenic mice infected
with T. canis. In that study, the investigators established
high eosinophil counts of peripheral blood on days 11 and
7 of infection in C3H/HeN mice. Oto et al. (14) studied

eosinophilia meningo-encephalo-myelitis due to T. canis.
At the end of the study, small numbers of leukocytes with
an increased rate of eosinophil (23.2%) were present. In
another study, Schaffer et al. (15) studied the
development and characterization of a model of
eosinophilia-mediated cardiomyopathy in rats infected
with T. canis. It was shown that T. canis develop marked
hypereosinophilia, with peak blood eosinophil levels of
approximately 3.500 eosinophil/µl whole blood, observed
approximately 14 days post-infection.
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In our study results, eosinophil counts in particular
increased in whole blood in T. canis infected mice in
Group 2. These increases were observed in three
sampling periods, on days 8, 15 and 28; 30.33 ±
2187.36, 1322.0 ± 742.66, and 790 ± 655.14,
respectively. In addition, eosinophil levels increased in
Group 4, with both infective T. canis eggs and
albendazole given. However, these increases were not as
large as in Group 2. In this respect our findings agree
with those of Schaffer et al. (15) in particular and those
of other investigators.
Therefore, after ingestion of infective T. canis eggs,
these hatch and larvae penetrate the gut wall and migrate
into various tissues, where they encyst. Humans are
accidental hosts who become infected by ingesting
infective eggs in contaminated soil. After ingestion, the
eggs hatch and larvae penetrate the intestinal wall and are
carried by the circulation to a wide variety of tissues, such
as the liver, heart, lungs, brain, muscle and eyes. They
also cause severe local reactions that are the basis of

toxocariasis (1-3). With this in mind we examined
biochemical enzyme activities in serum. According to our
results, serum urea, creatine and ALP activities decreased
slightly in T. canis infected mice in Group 2, and AST and
ALT activities in serum also increased in this group.
Serum AST activities in Group 2 were determined on days
8, 15 and 28 as follows; 248.80 ± 36.75, 347.50 ±
56.55 and 393.25 ± 118.34, respectively. Serum ALT
activities in these periods were 43.00 ± 17.95, 43.20 ±
10.80 and 45.5 ± 14.47, respectively. These changes,
which were particularly observed in Group 2, as high
serum AST activities, can be evaluated as the effects of T.
canis infection on the liver.
The findings obtained from this study showed that
total eosinophil counts in particular, and also total
leukocyte counts increased significantly in T. canis
infected mice. Although albendazole treatment prevented
the eosinophilia and leukocytosis to some degree, the
levels did not decrease compared to the control group
levels.
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